The nurse is providing care for a client who has been in a comatose state for several weeks. When performing a respiratory assessment, the nurse counts a respiratory rate of 28 and notes unlabored breathing. Upon auscultation of breath sounds, the nurse identifies diminished breath sounds, rhonchi, and crackles in the right lower lobe. What is the nurse's priority concern?

A. 1100. This time represents the passage of 2.5 hours, which is exactly one half-life of the medication. At this interval, only 50% of the initial 5 mg dose has been eliminated from the plasma. To reach 75% elimination, the drug must undergo a second half-life cycle to clear half of the remaining amount.

B. 1200. This interval is only 3.5 hours post-administration, which does not align with the completion of the required metabolic cycles. The drug concentration would still be significantly above the 25% retention threshold at this point. Pharmacokinetic clearance follows specific exponential decay intervals based on the established 2.5-hour half-life of Oxycodone.

C. 1330. After two half-lives, totaling 5 hours (2.5 plus 2.5), 75% of the drug is cleared from the systemic circulation. The first cycle reduces the dose to 50%, and the second cycle reduces that remaining half by another 50%. Starting from 0830, the addition of 5 hours correctly reaches the time of 1330.

D. 1600. This represents 7.5 hours since administration, which corresponds to the passage of three full half-lives. At this stage, approximately 87.5% of the drug would be eliminated, leaving only 12.5% in the body. This exceeds the 75% clearance threshold specified in the question regarding the metabolic rate of the dose.

A. Sublingual: This route provides rapid mucosal absorption for breakthrough pain but has a relatively short duration of action. It bypasses the gastrointestinal tract for quick systemic entry. However, it does not provide the sustained-release mechanism required for long-term, continuous analgesia.

B. Intravenous: IV administration offers the fastest onset of action but also the shortest duration due to rapid redistribution and clearance. It is ideal for acute, severe pain or titration in controlled settings. It lacks the slow-release properties necessary for extended pain management over several days.

C. Transdermal: Fentanyl patches utilize a rate-controlling membrane to deliver medication continuously through the dermis into the systemic circulation. This route typically provides a steady therapeutic plasma concentration for 48 to 72 hours. It is the preferred method for chronic, stable pain requiring long-acting relief.

D. Intramuscular: The intramuscular route has a slower onset than IV but still offers a limited duration of 2 to 4 hours. Repeated injections are painful and do not provide the consistent basal rate achieved by a patch. It is rarely used for fentanyl due to better alternatives.